X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet   (SUNP)

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 538.1
Mkt Cap Rs m 1,294,953
Vol '000 651.4
P/E X 24.2
P/CF X 14.2
EPS (TTM) Rs 22.2
% ch % 4.2
No. of shares m 2,406.75
% ch week % 2.3
% ch 1-mth % -0.4
% ch 12-mth % -22.1
52 week H/L Rs 730.8/433.2
(As on Nov 21, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs8486531,0741,201842 
Low Rs554493570706572 
Sales per share (Unadj.) Rs109.177.6132.3118.4131.6 
Earnings per share (Unadj.) Rs28.815.221.923.532.7 
Diluted earnings per shareRs12.413.118.923.532.6 
Cash flow per share (Unadj.) Rs32.117.127.727.838.0 
Dividends per share (Unadj.) Rs5.001.503.001.003.50 
Adj. dividends per shareRs2.151.292.581.003.49 
Dividend yield (eoy) %0.70.30.40.10.5 
Book value per share (Unadj.) Rs144.789.4135.2137.1152.7 
Adj. book value per shareRs62.377.0116.4137.0152.2 
Shares outstanding (eoy) m1,035.582,071.162,071.162,406.602,399.26 
Bonus/Rights/Conversions  -B1:1--- 
Price / Sales ratio x6.47.46.28.15.4 
Avg P/E ratio x24.337.837.540.621.6 
P/CF ratio (eoy) x21.933.429.734.318.6 
Price / Book Value ratio x4.86.46.17.04.6 
Dividend payout %17.49.913.74.310.7 
Avg Mkt Cap Rs m725,9421,186,7751,703,0112,294,8131,696,877 
No. of employees `00014.014.0NA14.717.5 
Total wages/salary Rs m15,34520,74445,02647,72349,023 
Avg. sales/employee Rs Th8,071.311,486.0NM19,317.218,028.3 
Avg. wages/employee Rs Th1,096.11,481.7NM3,236.12,798.8 
Avg. net profit/employee Rs Th2,130.82,243.9NM3,836.94,479.5 
SUN PHARMA INCOME DATA
Net Sales Rs m112,999160,804273,920284,870315,784 
Other income Rs m2,7632,6475,4776,5836,232 
Total revenues Rs m115,761163,451279,397291,453322,016 
Gross profit Rs m48,96272,87378,66781,583100,893 
Depreciation Rs m3,3624,09211,94710,37512,648 
Interest Rs m4324425,7905,2323,998 
Profit before tax Rs m47,93270,98666,40772,55890,479 
Minority Interest Rs m-4,863-7,375-9,36300 
Prior Period Items Rs m00-1261599 
Extraordinary Inc (Exp) Rs m-4,783-25,174-2,378-6,8520 
Tax Rs m8,4567,0229,1479,13812,116 
Profit after tax Rs m29,83131,41545,39456,58378,462 
Gross profit margin %43.345.328.728.631.9 
Effective tax rate %17.69.913.812.613.4 
Net profit margin %26.419.516.619.924.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m115,030186,865288,782299,413329,537 
Current liabilities Rs m28,41359,896153,294131,440178,870 
Net working cap to sales %76.779.049.559.047.7 
Current ratio x4.03.11.92.31.8 
Inventory Days Days8371768279 
Debtors Days Days7850688783 
Net fixed assets Rs m50,77158,242151,694180,477204,766 
Share capital Rs m1,0362,0712,0712,4072,399 
"Free" reserves Rs m136,274163,019278,009327,418363,997 
Net worth Rs m149,897185,250280,080329,825366,397 
Long term debt Rs m1,15348713,59831,10314,361 
Total assets Rs m205,827293,708501,601555,303614,102 
Interest coverage x112.1161.612.514.923.6 
Debt to equity ratio x0000.10 
Sales to assets ratio x0.50.50.50.50.5 
Return on assets %14.710.810.211.113.4 
Return on equity %19.917.016.217.221.4 
Return on capital %25.620.920.519.724.8 
Exports to sales %17.014.116.913.90 
Imports to sales %4.73.64.53.10 
Exports (fob) Rs m19,23822,71346,23539,5720 
Imports (cif) Rs m5,3535,77912,2298,8820 
Fx inflow Rs m19,61523,16848,70642,17144,118 
Fx outflow Rs m7,87712,62925,56421,58324,484 
Net fx Rs m11,73910,53923,14220,58819,634 
SUN PHARMA CASH FLOW
From Operations Rs m 33,566 39,592 56,157 66,859 70,822 
From Investments Rs m -26,351 -23,668 -28,657 -43,716 -42,216 
From Financial Activity Rs m -6,650 5,066 -11,865 -18,885 -22,854 
Net Cashflow Rs m 565 20,990 15,635 8,482 6,107 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.6

More Pharmaceuticals Company Fact Sheets:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare SUN PHARMA With:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare SUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Firm Note; Tech Mahindra Gains 3.3%(Closing)

Indian share markets continued to trade well above the dotted line in the afternoon session and finished in green for fourth consecutive day. At the closing bell, the BSE Sensex closed higher by 119 points

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

'Buy and Hold Forever' Not The Best Investing Style After All(The 5 Minute Wrapup)

Nov 9, 2017

Even Buffett didn't always Buy and Hold forever. A look at Berkshire's 1992 and 2017 portfolios will tell you the story...

Of Falling Real Estate Prices, Dr Arvind Panagariya and the Art of Continuing to Suck Up(Vivek Kaul's Diary)

Nov 13, 2017

Dr Panagariya claims real estate prices have fallen 25 per cent post demonetisation; the official data doesn't show anything like that.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

You're Lucky You Missed Out on that IPO...(Smart Contrarian)

Nov 8, 2017

Here's how to profit from upcoming IPOs.

Why I am the Biggest India Equity Bull on Planet Earth!(The Honest Truth)

Nov 16, 2017

If you have a dream, dream big...about the level of BSE 30 index in 2050!

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - TEVA PHARMA COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS